| 1 | LLY | Eli Lilly and Company | 18.14% |
| 2 | ABBV | AbbVie Inc. | 9.12% |
| 3 | n/a | US BANK MMDA - USBGFS 7 | 8.71% |
| 4 | NVSN.MX | Novartis AG ADR | 6.18% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.72% |
| 6 | AZN | AstraZeneca PLC | 5.27% |
| 7 | JNJ | Johnson & Johnson | 5.05% |
| 8 | IONS | Ionis Pharmaceuticals, Inc. | 4.72% |
| 9 | AMGN | Amgen Inc. | 4.10% |
| 10 | BMY | Bristol-Myers Squibb Company | 3.98% |
| 11 | ALKS | Alkermes plc | 3.36% |
| 12 | MRK | Merck & Co., Inc. | 3.30% |
| 13 | PFE | Pfizer Inc. | 3.27% |
| 14 | REGN | Regeneron Pharmaceuticals, Inc. | 2.75% |
| 15 | BIIB | Biogen Inc. | 2.72% |
| 16 | CRSP | CRISPR Therapeutics AG | 2.69% |
| 17 | GSK | GSK plc | 2.69% |
| 18 | GALT | Galectin Therapeutics Inc. | 1.60% |
| 19 | BEAM | Beam Therapeutics Inc. | 1.02% |
| 20 | HLN | Haleon plc | 0.70% |
| 21 | REPL | Replimune Group, Inc. | 0.67% |
| 22 | SDZNY | Sandoz Group AG | 0.66% |
| 23 | VNDA | Vanda Pharmaceuticals Inc. | 0.65% |
| 24 | NTLA | Intellia Therapeutics, Inc. | 0.60% |
| 25 | BCYC | Bicycle Therapeutics plc | 0.46% |
| View MEDX holdings |
